RobertBLorsbachMD
Pathology • Little Rock, ARHematopathology, Anatomic Pathology, Clinical Pathology
Associate Professor, Pathology, University of Arkansas COM
Dr. Lorsbach is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4301 W Markham St
#517 University Of Arkansas For Medical Sciences
Little Rock, AR 72205Phone+1 501-686-8310Fax+1 501-603-1479- Is this information wrong?
Education & Training
Brigham and Women's HospitalFellowship, Hematopathology, 1998 - 1999- Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1994 - 1998
University of Kansas School of MedicineClass of 1994
Certifications & Licensure
OH State Medical License 2014 - 2024
AR State Medical License 2006 - 2014
TN State Medical License 1999 - 2007
MA State Medical License 1998 - 2000- American Board of Pathology Anatomic Pathology
- American Board of Pathology Hematology
Publications & Presentations
PubMed
- Dabrafenib and trametinib in Langerhans cell histiocytosis and other histiocytic disorders.Eily Cournoyer, Justin Ferrell, Susan Sharp, Anish Ray, Michael Jordan, Christopher Dandoy, Michael Grimley, Somak Roy, Robert Lorsbach, Arnold C Merrow, Adam Nelson, ...> ;Haematologica. 2024 Apr 1
- 19 citationsHematologic Complications with Age in Shwachman-Diamond Syndrome.Elissa Furutani, Shanshan Liu, Ashley Galvin, Sarah K. Steltz, Maggie Malsch, Sara Loveless, Leann Mount, Jordan Henry Larson, Kelan Queenan, Alison A. Bertuch, Mark D...> ;Blood Advances. 2021 Nov 10
- 50 citationsALK+ histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.Paul Geraeds Kemps, Jennifer Picarsic, Benjamin H. Durham, Zofia Hélias-Rodzewicz, Laura Sophia Hiemcke-Jiwa, Cor van den Bos, Marianne D. van de Wetering, Carel J. M....> ;Blood. 2021 Nov 2
- Join now to see all
Abstracts/Posters
- V2 Trial: A Phase I Study of Venetoclax Combined with CPX-351 for Children, Adolescents and Young Adults with Relapsed or Refractory Acute LeukemiaRobert B. Lorsbach, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- VPS4A mutations Cause a Syndrome with Dyserythropoiesis, Hemolytic Anemia, and Neurodevelopmental DelayRobert B. Lorsbach, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Congenital Dyserythropoietic Anemia Type I Due to Biallelic CDAN1 mutations: Report from the Congenital Dyserythropoietic Anemia Registry (CDAR)Robert B. Lorsbach, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Hospital Affiliations
Cincinnati Children's Hospital Medical CenterCincinnati, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
